Quarterly ResultMay 7, 2026, 07:32 AM
EDAP Reports Record Q1 HIFU Revenue of $11.6M, Up 78%
AI Summary
EDAP TMS SA reported strong first-quarter 2026 financial results, driven by record High-Intensity Focused Ultrasound (HIFU) revenue of $11.6 million, a 78% increase year-over-year. The company saw significant growth in U.S. Focal One procedures, up 53%, and an 83% increase in Focal One system shipments. Total revenue for the quarter reached $17.8 million, with an improved gross profit margin of 45.7%. EDAP also reiterated its 2026 financial guidance for both its core HIFU and non-core businesses.
Key Highlights
- Q1 HIFU revenue grew 78% year-over-year to $11.6 million.
- U.S. Focal One procedures increased by 53% year-over-year.
- Focal One system shipments rose 83% year-over-year to eleven systems.
- Total worldwide revenue for Q1 2026 was $17.8 million, up from $14.3 million in Q1 2025.
- Gross profit margin improved to 45.7% from 42.0% in the prior year.
- Net loss for Q1 2026 was $9.1 million, or ($0.24) per share.
- Reiterated 2026 core HIFU revenue guidance of $50.0 million to $54.0 million.